Skip to content
(614)355-5560
West Region
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids

Since the discontinuation of brand name Flovent®, there have been many challenges with patient access to spacer-compatible inhaled steroids that are appropriate for children with asthma. Even though fluticasone propionate HFA (authorized generic of Flovent®), is a covered option for Ohio Medicaid patients, there still may be shortages at the pharmacy to overcome. In response, Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children.  Included in this resource is standard language that will assist with proper communication to insurance companies if a prior authorization is requested. 

If you have questions, please reach out to the Partners For Kids pharmacy team at PFKPharmacy@ChildrensDayton.org

Related Articles
Pharmacy Updates
October 1, 2025
Quarterly Updates: PFK’s Pediatric-focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
October 1, 2025
Quarterly Updates: PFK’s Pediatric-focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
October 1, 2025
RSV/Nirsevimab Toolkit
Read More
Pharmacy Updates
October 1, 2025
RSV/Nirsevimab Toolkit
Read More
Pharmacy Updates
August 20, 2025
Respiratory Syncytial Virus (RSV) Prevention Toolkit Now Available
Read More
Pharmacy Updates
August 20, 2025
Save The Date: Upcoming Primary Care Education Series
Read More